AKINCI, B. Et Al. 2011. Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels Are not Associated With Glucose Intolerance and Subclinical Atherosclerosis in Women With Previous Gestational Diabetes. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.6 .

AKINCI, B., ÇELTİK, A., Yener, S., Genc, S., TUNALI, S., YÜKSEL, F., ... ÖZCAN, M. A.(2011). Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels Are not Associated With Glucose Intolerance and Subclinical Atherosclerosis in Women With Previous Gestational Diabetes. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.6.

AKINCI, BARIŞ Et Al. "Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels Are not Associated With Glucose Intolerance and Subclinical Atherosclerosis in Women With Previous Gestational Diabetes," CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.6, 2011

AKINCI, BARIŞ Et Al. "Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels Are not Associated With Glucose Intolerance and Subclinical Atherosclerosis in Women With Previous Gestational Diabetes." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.6, 2011

AKINCI, B. Et Al. (2011) . "Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels Are not Associated With Glucose Intolerance and Subclinical Atherosclerosis in Women With Previous Gestational Diabetes." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.6.

@article{article, author={BARIŞ AKINCI Et Al. }, title={Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels Are not Associated With Glucose Intolerance and Subclinical Atherosclerosis in Women With Previous Gestational Diabetes}, journal={CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS}, year=2011}